Awards Nomination 20+ Million Readerbase
PMC/PubMed Indexed Articles
Development and Application of Cancer Stem Cell-Targeted Vaccine in Cancer Immunotherapy
MEFA (multiepitope fusion antigen)-Novel Technology for Structural Vaccinology, Proof from Computational and Empirical Immunogenicity Characterization of an Enterotoxigenic Escherichia coli (ETEC) Adhesin MEFA

View More »

Google Scholar citation report
Citations : 2341

Journal of Vaccines & Vaccination received 2341 citations as per Google Scholar report

Journal of Vaccines & Vaccination
Journal of Vaccines & Vaccination peer review process verified at publons
Flyer image
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Scimago
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
View More
Useful Links
Share This Page
Open Access Journals
View More

Bartira Rossi Bergmann

Bartira Rossi Bergmann

Laboratório de Imunofarmacologia, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, 21941-902 Rio de Janeiro, RJ, Brazil

Biography
Dr. Bartira Rossi-Bergmann is biomedical, formed in 1981 from the Faculty of Medicine of Ribeirão Preto - USP. Concluded in 1982 a master's degree at the London School of Hygiene and Tropical Medicine (England), and in 1987 his doctorate at Brunel University (England) on Immunology leishmaniasis and trypanosomiasis African, respectively. After two years as a visiting researcher at the Oswaldo Cruz Foundation in 1989 he came by public tender in the Federal University of Rio de Janeiro - UFRJ. In 1994, a post-doc at the University of Toronto (Canada) where he researched the feasibility of tolerogenic vaccines in transplants. 
Research Interest
Parasitology, Immunology and Nanotechnology, more specifically Nanofármacos and Nano vaccines